# Minocycline in Stroke Study at Maimonides

Study · id `cardio:ct-nct07237048` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07237048](<https://clinicaltrials.gov/study/NCT07237048>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07237048

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1164 participants.

## Technical summary

Registry record NCT07237048. Randomized; single masking; primary purpose treatment. Start 2026-02-02 (actual); primary completion 2028-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 1164 participants (planned count; ClinicalTrials.gov record NCT07237048, source copy `cardio:ctgov-nct07237048-2026-03-19`, retrieved 2026-10-26)
- Started: 2026-02-02 (actual) (ClinicalTrials.gov record NCT07237048, source copy `cardio:ctgov-nct07237048-2026-03-19`, retrieved 2026-10-26)
- Primary completion: 2028-12-01 (anticipated) (ClinicalTrials.gov record NCT07237048, source copy `cardio:ctgov-nct07237048-2026-03-19`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07237048, source copy `cardio:ctgov-nct07237048-2026-03-19`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07237048, source copy `cardio:ctgov-nct07237048-2026-03-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07237048-2026-03-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Minocycline in Stroke Study at Maimonides
- Condition: Stroke
- Condition: Ischemia Stroke
- Condition: Hemorrhagic Strokes
- Condition: Mortality
- Condition: Morbidity
- Condition: Cerebrovascular Accident (Stroke)
- Condition: Intracerebral Haemorrhage (ICH)
- Intervention (Drug): Minocycline 200mg
- Lead sponsor: Joyce Chen
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 1619687a7ba7b00a688a88fa0a602ca89e90e6022d75ba0497168c3fd6ffb484
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
